Total Payments
$24,933
2024 Payments
$7,119
Companies
45
Transactions
476
Medicare Patients
2,058
Medicare Billing
$251,995
Payment Breakdown by Category
Consulting$14,706 (59.0%)
Food & Beverage$8,874 (35.6%)
Other$1,250 (5.0%)
Education$103.41 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,706 | 9 | 59.0% |
| Food and Beverage | $8,874 | 459 | 35.6% |
| Honoraria | $1,000 | 1 | 4.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 2 | 1.0% |
| Education | $103.41 | 5 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $7,042 | 61 | $0 (2024) |
| Ardelyx, Inc. | $2,875 | 2 | $0 (2024) |
| Janssen Global Services, LLC | $2,874 | 1 | $0 (2023) |
| ABBVIE INC. | $2,420 | 137 | $0 (2024) |
| Mahana Therapeutics, Inc. | $2,376 | 4 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $1,905 | 2 | $0 (2022) |
| Celgene Corporation | $909.02 | 41 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $843.13 | 53 | $0 (2024) |
| PFIZER INC. | $590.80 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $340.29 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,119 | 72 | Janssen Biotech, Inc. ($4,639) |
| 2023 | $8,201 | 94 | Janssen Global Services, LLC ($2,874) |
| 2022 | $5,606 | 78 | Mahana Therapeutics, Inc. ($2,376) |
| 2021 | $1,116 | 48 | Celgene Corporation ($420.29) |
| 2020 | $316.16 | 20 | AbbVie Inc. ($179.51) |
| 2019 | $740.75 | 60 | Takeda Pharmaceuticals U.S.A., Inc. ($168.13) |
| 2018 | $847.95 | 41 | Shire North American Group Inc ($250.00) |
| 2017 | $986.79 | 63 | AbbVie, Inc. ($257.14) |
All Payment Transactions
476 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: LIVER DISEASE | ||||||
| 11/18/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: GI | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $138.60 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/27/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $64.71 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $34.16 | General |
| Category: GI | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $27.33 | General |
| Category: Immunology | ||||||
| 10/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $31.63 | General |
| Category: Rare Disease | ||||||
| 09/16/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.82 | General |
| Category: GI | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.11 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.74 | General |
| Category: Neuroscience | ||||||
| 08/13/2024 | Celltrion USA Inc. | ZYMFENTRA (Biological) | Education | In-kind items and services | $16.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $119.23 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/01/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 539 | 596 | $475,164 | $67,659 |
| 2022 | 11 | 589 | 628 | $432,738 | $71,348 |
| 2021 | 11 | 483 | 534 | $352,023 | $60,149 |
| 2020 | 9 | 447 | 519 | $258,415 | $52,839 |
Total Patients
2,058
Total Services
2,277
Medicare Billing
$251,995
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 119 | 148 | $51,504 | $15,273 | 29.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 117 | 120 | $179,529 | $13,973 | 7.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 53 | 54 | $77,004 | $12,609 | 16.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 69 | 73 | $86,098 | $6,283 | 7.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 86 | $20,382 | $6,005 | 29.5% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 15 | 15 | $16,478 | $2,875 | 17.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $9,666 | $2,665 | 27.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $10,298 | $2,431 | 23.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $11,840 | $2,224 | 18.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $5,005 | $1,248 | 24.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 16 | $3,792 | $1,102 | 29.1% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 11 | 16 | $3,568 | $972.32 | 27.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 110 | 110 | $147,730 | $15,805 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 103 | 116 | $40,368 | $11,902 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 125 | 146 | $34,602 | $11,344 | 32.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 78 | 80 | $89,920 | $7,100 | 7.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $22,222 | $5,795 | 26.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 21 | 21 | $29,946 | $4,849 | 16.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 50 | 50 | $17,900 | $3,807 | 21.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 18 | 18 | $19,044 | $3,765 | 19.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 17 | 17 | $18,071 | $3,559 | 19.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $9,380 | $2,477 | 26.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 12 | 15 | $3,555 | $944.35 | 26.6% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 94 | 94 | $126,242 | $14,605 | 11.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 165 | $39,105 | $12,667 | 32.4% |
About Asma Khapra
Asma Khapra is a Gastroenterology healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1770702011.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Asma Khapra has received a total of $24,933 in payments from pharmaceutical and medical device companies, with $7,119 received in 2024. These payments were reported across 476 transactions from 45 companies. The most common payment nature is "Consulting Fee" ($14,706).
As a Medicare-enrolled provider, Khapra has provided services to 2,058 Medicare beneficiaries, totaling 2,277 services with total Medicare billing of $251,995. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Fairfax, VA
- Active Since 04/25/2007
- Last Updated 08/05/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1770702011
Products in Payments
- STELARA (Biological) $5,573
- TREMFYA (Drug) $4,362
- IBSRELA (Drug) $2,875
- ZEPOSIA (Drug) $995.15
- RINVOQ (Biological) $566.83
- ENTYVIO (Biological) $518.39
- SKYRIZI (Biological) $498.17
- Humira (Biological) $488.24
- XELJANZ (Drug) $456.40
- HUMIRA (Biological) $427.15
- DUPIXENT (Biological) $403.63
- LINZESS (Drug) $294.63
- Entyvio (Biological) $291.06
- XIFAXAN (Drug) $254.85
- GATTEX (Drug) $250.00
- VIBERZI (Drug) $173.46
- Linzess (Drug) $147.95
- Sucraid (Drug) $130.95
- VELSIPITY (Drug) $121.43
- Cimzia (Drug) $116.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fairfax
Dr. Ali Siddiqui, Md, MD
Gastroenterology — Payments: $200,158
Gastroenterology $200,158
Dr. Michael Garone, M.d, M.D
Gastroenterology — Payments: $50,484
Gastroenterology $50,484
Dr. Jeremias Tan, M.d, M.D
Gastroenterology — Payments: $16,746
Gastroenterology $16,746
Dr. Richard Blosser, M.d, M.D
Gastroenterology — Payments: $15,267
Gastroenterology $15,267
Dr. Tonya Adams, M.d, M.D
Gastroenterology — Payments: $13,340
Gastroenterology $13,340
Dr. Mahmood Abedi, Md, MD
Gastroenterology — Payments: $9,941
Gastroenterology $9,941